NxGEN Vector Solutions, LLC
NxGEN will design your CpG-depleted AAV vector constructs.
Let NxGEN design your AAV vector sequence using our patented CpG-depletion technology to get your platforms up and running faster. A reduction in immune response to a transgene product from an AAV vector expression cassette that contains fewer CpG di-nucleotides than an unmodified AAV vector results in safe, effective, and durable therapeutic gene expression as seen both preclinically and clinically. We use our expertise and vector design strategies to decrease the number of CpG motifs in your AAV vector and provide you the highest quality sequences with the greatest success rate.